James Sherblom, Director at Comera Life Sciences Holdings, Inc. (CMRA), bought 81,081 shares at $1.23 ($100K) on 2023-01-04, disclosed to the SEC on 2023-02-14.
Open-market purchase of $100k CMRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.